Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:23 PM
Ignite Modification Date:
2025-12-24 @ 5:23 PM
NCT ID:
NCT06244550
Eligibility Criteria:
Inclusion Criteria:
* Must be willing to participate in the study and provide written informed consent.
* Male and female adults ≥20 and \<80 years of age.
* Suspected or confirmed diagnosis of NAFLD:
* Fibroscan with CAP ≥220 dB/m
* Criteria for diagnosing fatty liver: Abdominal ultrasound reveals differences in liver and kidney parenchyma due to wave reflection, liver parenchymal ultrasound attenuation, and blurred imaging of liver vessels and diaphragm, indicating fatty liver.
Exclusion Criteria:
* Female patients who are pregnant or breastfeeding.
* Diabetic patients undergoing medication treatment.
* Patients clinically diagnosed with alcoholic hepatitis, autoimmune hepatitis, or biliary liver disease.
* Excessive alcohol consumption (more than 15 grams/day for females, more than 30 grams/day for males).
* Users of weight-loss products and vitamin E supplements.
* Individuals with an estimated Glomerular Filtration Rate (eGFR) less than 60 mL/min/1.73m².
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT06244550
Study Brief:
Protocol Section:
NCT06244550